Stoma/Ostomy Care Market is expected to reach US$ 6.5 Billion by the end of 2033

By the end of 2022, the global stoma/ostomy care market is expected to be worth US$ 3.8 billion. During the forecast period of 2023 to 2033, the market is estimated to grow at a CAGR of 4.9%, with a market value of roughly US$ 6.5 billion in 2033.

The rising prevalence of target diseases, advancements in ostomy goods and surgical methods, increased awareness, and reimbursements all contribute to the growth of the stoma care market.

To get more insights, Download Sample Copy@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14261

Colorectal cancer, bladder cancer, and inflammatory bowel disease are the most common illnesses that necessitate ostomy care procedures. Colorectal cancer and inflammatory bowel disease are treated with surgical excision of aggressive melanoma of the intestine (IBD). In some cases, a surgical incision through the abdomen is made to provide a new waste minimization conduit known as an ostomy.

Because of an increase in the occurrence of these illnesses and greater exposure to risk factors, such as changing eating habits and increasing antibiotic use in children, the adoption of stoma/ostomy care procedures performed worldwide has increased.

Despite recent advances in stoma care, the stoma/ostomy market faces a greater number of restraints that limit growth potential. Stoma care issues, discomfort, and other concerns associated with ostomy goods, societal stigma, and increased acceptance of alternative therapies, particularly in developing countries, are likely to restrain the market.

Although stomas are a relatively common and safe surgery, there are some risks involved. Although most stoma problems are minor, some, particularly necrosis and exhaustion, can be life-threatening. These issues limit the acceptance of stoma care appliances to some extent.

Contact Us for a Discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-14261

Key Takeaways:

• The USA market will hold the market share of around 28.7% in 2023 global market.
• The Germany is set to hold around 5.3% of global market share in stoma/ostomy care in 2023.
• The Indian market is projected to expand at a CAGR of 3.8% during the forecast period.
• Due to a growing number of patients suffering from target diseases such as colorectal cancer, Ostomy Bags is predicted to occupy a considerable revenue share of 84.3% in the global market by 2023.
• Due to the rising frequency of IBD, bowel cancer, and colon cancer in both developed and developing nations, as well as the favourable reimbursement environment in developed countries, the colostomy sector is predicted to hold a high market share of 88.8% in the global market in 2023.

“Improvement in product design will remain a key differentiator as end users have to face stigma with the drainage bags.” reports FMI analyst.

Competitive Landscape

The European market for stoma/ostomy care is the largest. However, according to recent trends, key players are focusing on the Asia Pacific market due to low labour costs and a large pool of patients.

• Coloplast Singapore released SenSura Mio in February 2022, which uses the most latest elastic adhesive technology and is appropriate for all peristomal body profiles. SenSura® Mio is being offered in Singapore for the first time in Southeast Asia with the goal of improving the quality of life for ostomytes, or those who have had an ostomy and now have a stoma.
• Trio Healthcare received financing from SWK Holdings Corporation, a specialised finance company based in the United States, in February 2020, in order to accomplish significant local and global expansion ahead of an anticipated product launch in 2021.

Key players in the Stoma/Ostomy Care Market

BAE Systems Plc, ConvaTec Inc., Hollister Inc., EuroMed, Inc, 3M Company, Smith & Nephew plc, FNC Medical, Nu–Hope Laboratories, Inc., Marlen Manufacturing & Development Co., Torbot Group, Inc, Cymed Micro Skin, Alcare Co., Ltd., B. Braun Melsungen AG., Salts Healthcare Ltd, Securi–T USA., Welland Medical Limited, Flexicare Group Limited.

Request Customization of Report@ https://www.futuremarketinsights.com/customization-available/rep-gb-14261

Key Segments

By Surgery Type:

• Colostomy
• Ileostomy
• Urostomy

By Product:

• Ostomy Bags
• Ostomy Accessories
  • Belts & Tapes
  • Skin Protection &Skin Barrier
  • Irrigation Sets
  • Convex Inserts
  • Stoma Caps

By Application:

• Cancer
• Inflammatory Bowel Disease
• Bowel Obstruction
• Fecal Incontinence
• Trauma and Infection

By End–Users:

• Hospitals and Specialty Clinics
• Home Care Settings
• Ambulatory Surgical Centers

About Future Market Insights, Inc.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs